Shuttle Pharmaceuticals | 8-K:咨询协议
Shuttle Pharmaceuticals | 3:首次持股声明-董事 Tung Joseph
Shuttle Pharmaceuticals | 3:首次持股声明-董事 Nabyt Oleh
Shuttle Pharmaceuticals | 3:首次持股声明-董事 Scorsis George
Shuttle Pharmaceuticals | PRE 14A:并购重组委托声明
Shuttle Pharmaceuticals | 8-K:Shuttle Pharmaceuticals宣布完成575万美元承销发行
Shuttle Pharmaceuticals | 424B3:募资说明书
Shuttle Pharmaceuticals | 8-K:Shuttle Pharmaceuticals宣布任命Christopher Cooper为临时联席首席执行官以加强业务活动
Shuttle Pharmaceuticals | EFFECT:其他
Shuttle Pharmaceuticals | S-1/A:证券上市注册声明(修正)
Shuttle Pharmaceuticals | 8-K:循环贷款协议
Shuttle Pharmaceuticals | 424B3:募资说明书
Shuttle Pharmaceuticals | 424B3:募资说明书
Shuttle Pharmaceuticals | 424B3:募资说明书
Shuttle Pharmaceuticals | 8-K:修订协议
Shuttle Pharmaceuticals | 8-K:Shuttle Pharmaceuticals提供公司最新情况并报告2024年业绩
Shuttle Pharmaceuticals | 10-K:2024财年年报
Shuttle Pharmaceuticals | SCHEDULE 13G:其他
Shuttle Pharmaceuticals | S-1:证券上市注册声明
Shuttle Pharmaceuticals | 5/A:权益变更年度报表(修正)-董事 Schafer Joshua